Clinical Trial Update: A Clinical Trial to Assess the Effectiveness of NRF2 Activator (Oral Sodium-copper- Chlophyllin ) in Locally Advanced Cervical Cancer to Reduce Late Radiotherapy Toxicity. [Phase 3]

View source ↗

Summary

This document describes a Phase 3 clinical trial evaluating whether oral sodium copper chlorophyllin, an NRF2 activator, can reduce late radiotherapy toxicity i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Sodium copper chlorophyllin (Sodium copper chlorophyllin)

Snippet

Sponsor: Tata Memorial Hospital | Conditions: Uterine Cervical Neoplasm | Phase 3 | Status: NOT_YET_RECRUITING